Centenarians and nonagenarians exemplify healthy aging, yet their immunity is understudied. We defined anti-viral immunity in centenarians and nonagenarians in comparison to children, adults and older adults. We investigated transcriptional and protein profiles of anti-viral epitope-specific CD8+ T cells as well as innate immunity in long-lived centenarians and nonagenarians to provide insights into reduced susceptibility to life-threatening viral infections across pandemics and epidemics. We combined 10x scRNAseq, CITE-seq (130 immune-related protein markers) and DNA-barcoded peptide/HLA-I tetramers specific for influenza A and B, SARS-CoV-2, EBV and CMV to define antigen-specific CD8+ T cells from children (5-15yrs), adults (24-39yrs), older adults (68-75yrs) and long-lived individuals (93-102yrs). We established key transcriptomic and protein signatures underpinning virus-specific CD8+ T cells in healthy aging. Our analyses revealed distinct innate features as well as virus-specific CD8+ T cell signatures from children to long-lived individuals, with more differentiated memory CD8+ T cell subsets in centenarians and nonagenarians expressing unique transcriptomic signatures. Distinct age-specific transcriptomic signatures were also observed for epitope-specific CD8+ T cell populations directed towards chronic and acute viruses. We also deciphered in-depth myeloid and NK cell immunity across the human lifespan. Overall, our study identified immune profiles underpinning innate immunity and virus-specific CD8+ T cells across the human lifespan and provides key insights into immune signatures associated with healthy aging that may identify potential therapeutic targets to reduce disease severity.